chartexchange

CTSO
Cytosorbents Corp.
stockNASDAQ

At CloseNov 17, 2026 3:18:19 PM EST
4.80USD-0.928%(-0.05)36,959
After-hoursNov 17, 2026 4:00:30 PM EST
4.52USD-5.931%(-0.28)
4.3400Bid5.7400Ask1.4000Spread
Loading…
Loading…
Healthcare
Medical Devices
CEO
Phillip Chan
HQ
Princeton, NJ, USA
Previous Close
$4.85
Beta
1.19
52-Week High
$17.00 2025-11-24
52-Week Low
$2.84 2026-10-15
SMA 50
$4.83
SMA 200
$9.02
Avg. Vol 10D
19,046
Avg. Vol 30D
55,308
Avg. Vol 90D
26,803
Relative Vol
0.66
2.71M
1.1500%
261
Sep 8, 2026 · 1-for-20 (reverse)
CTSO Profile

cytosorbents (nasdaq: ctso) cytosorbents corporation is a leader in critical care immunotherapy, specializing in blood purification. its flagship product, cytosorb® is approved in the european union with distribution in 40 countries around the world, as a safe and effective extracorporeal cytokine adsorber, designed to reduce the "cytokine storm"​ or "cytokine release syndrome"​ that could otherwise cause massive inflammation, organ failure and death in common critical illnesses such as sepsis, burn injury, trauma, lung injury and pancreatitis, as well as in cancer immunotherapy. these are conditions where the risk of death is extremely high, yet no effective treatments exist. cytosorb® is also being used during and after cardiac surgery to remove inflammatory mediators, such as cytokines and free hemoglobin, which can lead to post-operative complications, including multiple organ failure. cytosorbents'​ purification technologies are based on biocompatible, highly porous polymer beads

CTSO Performance
PeriodPriceDateChangeBeta
1W5.802026-11-10-21.55%-2.315
1M4.112026-10-16+10.71%1.362
3M7.542026-08-17-39.69%0.989
6M9.582026-05-18-52.51%1.182
1Y13.122025-11-17-65.33%1.188
2Y18.602024-11-18-75.54%—
5Y121.402021-11-17-96.25%0.890
CTSO Stock Summary

Cytosorbents Corp. (NASDAQ:CTSO) stock price today is $4.55, and today's volume is 36,727. CTSO is down 6.186% today. The 30 day average volume is 55,308. CTSO market cap is $14.34M with 3.15M shares outstanding.